ScitoVation, founded with a mission to enhance human health through scientific and technological advancements, is a biotechnology company that specializes in understanding the effects of chemical compounds and drugs. The firm offers services that include safety and efficacy assessments of pharmaceuticals, chemicals, food ingredients, and cosmetics. Utilizing New Approach Methods (NAMs), ScitoVation aims to help clients develop safer and more effective products in a faster and more efficient manner.
Notable figures affiliated with ScitoVation include Dr. Paul White, known for his expertise in quantitative interpretation of genotoxicity dose-response data. The company has garnered recognition for its successful partnerships and flexibility in addressing client needs. ScitoVation's impact is evident in its contributions to global health, providing critical insights that aid in the development of safer consumer products and pharmaceuticals.
